Proton Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Proton Therapy Market: By Type of System (Single Room System and Multi-Room System), By Application (Paediatric Cancer, Head & Neck Cancer, Prostate Cancer, Lung Cancer, Gastro-Intestinal Cancer, Brain Cancer and Others), By End-User (Hospitals, Radiotherapy Centers and Others) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market Outline: Global Proton Therapy Market
Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels protons can destroy the cancer cells. Proton therapy is a non-invasive procedure in which proton radiation used to treat cancer. Proton therapy is a type of external beam radiation therapy, that painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with the other treatments such as surgery, chemotherapy, general radiation therapy and or immunotherapy.
Market dynamics: Global Proton Therapy Market
Global proton therapy market is mainly driven by an increase in the adaptation of non-invasive therapies in the treatment of cancer. In addition, growing number of radiation centers globally coupled with the increase in the prevalence of the cancer cases expected to fuel the market growth over the forecast period. Furthermore, proton therapy is more advantageous than the other radiation therapies. Proton therapy delivers up to 60% less radiation to healthy tissue around the tumor and has fewer side effects during and after the treatment. Based on above-mentioned factors global proton therapy market is expected to increase its traction over the forecast period. However, a high cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period.
Market Scope: Global Proton Therapy Market
Global proton therapy market is segmented based on type of system, application and end user
Based on type of system, global proton therapy market is segmented into
Global proton therapy market is expected to grow at significant CAGR rates during the forecast period owing to the factors such as growing prevalence of cancer and adaptation of non-invasive techniques such as radiation therapy to treat the cancer tumors. Companies in proton therapy market are striving to increase its market share by the development of the innovative treatment options through proton radiation therapy to treat various cancer tumors. For instance, in September 2017, Elekta and Ion Beam Applications (IBA) has entered into a collaboration to work closely together in software development as well as sales and marketing of each other products. Under the agreement, Companies seeks to develop a novel functionality for the proton therapy treatment in Monaco treatment planning system of Elekta and MOSAIQ oncology information system. Furthermore, companies also acquiring other competitors and adapting strategies such as mergers and geographical expansions to strengthen their position in the market.
Regional Analysis: Global Proton Therapy Market
Geographically proton therapy market is divided into five key regions, i.e., North America, Europe, Asia-Pacific, Latin America, The Middle East & Africa. North America proton therapy market is expected to grow at notable rates owing to the factors such as growing number of cancer patients favorable reimbursement scenario and growing awareness related to radiotherapy advantages over the other treatment procedures. Asia Pacific proton therapy market is expected to grow at notable rates owing to the factors such as growing number of cancer patients in the region, additionally, developing hospital infrastructure coupled with the increase in healthcare spending projected to boost the proton therapy market in the region. Furthermore, the establishment of new radiotherapy centers for treatment of cancer by well-established healthcare providers such as Apollo in India may drive the proton therapy market share in the region.
COMPETITION ASSESSMENT: GLOBAL PROTON THERAPY MARKET
Key players in global proton therapy market include
In September 2017, Mevion Medical Systems announced the submission of 510 (K) premarket notifications to U.S. Food and Drug Administration for its proton therapy system MEVION S250i with pencil beam hyper scan technology.
In October 2014, Hitachi Ltd. And its development partner, Hokkaido University launched a new single room compact 360-degree proton beam therapy system
KEY FEATURES OF THE REPORT:
Market Outline: Global Proton Therapy Market
Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels protons can destroy the cancer cells. Proton therapy is a non-invasive procedure in which proton radiation used to treat cancer. Proton therapy is a type of external beam radiation therapy, that painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with the other treatments such as surgery, chemotherapy, general radiation therapy and or immunotherapy.
Market dynamics: Global Proton Therapy Market
Global proton therapy market is mainly driven by an increase in the adaptation of non-invasive therapies in the treatment of cancer. In addition, growing number of radiation centers globally coupled with the increase in the prevalence of the cancer cases expected to fuel the market growth over the forecast period. Furthermore, proton therapy is more advantageous than the other radiation therapies. Proton therapy delivers up to 60% less radiation to healthy tissue around the tumor and has fewer side effects during and after the treatment. Based on above-mentioned factors global proton therapy market is expected to increase its traction over the forecast period. However, a high cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period.
Market Scope: Global Proton Therapy Market
Global proton therapy market is segmented based on type of system, application and end user
Based on type of system, global proton therapy market is segmented into
- Single Room System
- Multi-Room System
- Paediatric Cancer
- Head & Neck Cancer
- Prostate Cancer
- Lung Cancer
- Gastro-Intestinal Cancer
- Brain Cancer
- Others
- Hospitals
- Radiotherapy Centres
- Others
Global proton therapy market is expected to grow at significant CAGR rates during the forecast period owing to the factors such as growing prevalence of cancer and adaptation of non-invasive techniques such as radiation therapy to treat the cancer tumors. Companies in proton therapy market are striving to increase its market share by the development of the innovative treatment options through proton radiation therapy to treat various cancer tumors. For instance, in September 2017, Elekta and Ion Beam Applications (IBA) has entered into a collaboration to work closely together in software development as well as sales and marketing of each other products. Under the agreement, Companies seeks to develop a novel functionality for the proton therapy treatment in Monaco treatment planning system of Elekta and MOSAIQ oncology information system. Furthermore, companies also acquiring other competitors and adapting strategies such as mergers and geographical expansions to strengthen their position in the market.
Regional Analysis: Global Proton Therapy Market
Geographically proton therapy market is divided into five key regions, i.e., North America, Europe, Asia-Pacific, Latin America, The Middle East & Africa. North America proton therapy market is expected to grow at notable rates owing to the factors such as growing number of cancer patients favorable reimbursement scenario and growing awareness related to radiotherapy advantages over the other treatment procedures. Asia Pacific proton therapy market is expected to grow at notable rates owing to the factors such as growing number of cancer patients in the region, additionally, developing hospital infrastructure coupled with the increase in healthcare spending projected to boost the proton therapy market in the region. Furthermore, the establishment of new radiotherapy centers for treatment of cancer by well-established healthcare providers such as Apollo in India may drive the proton therapy market share in the region.
COMPETITION ASSESSMENT: GLOBAL PROTON THERAPY MARKET
Key players in global proton therapy market include
- IBA (Ion Beam Applications S.A.) (Belgium)
- Hitachi, Ltd. (Japan)
- Varian Medical Systems (U.S.)
- Mitsubishi Electric Corporation (Japan)
- Optivus Proton Therapy, Inc. (U.S.)
- Mevion Medical Systems (U.S.)
- Advanced Oncotherapy plc (U.K.)
- ProTom International Inc, (U.S.)
- ProNova Solutions LLC (U.S.)
- Sumitomo Heavy Industries, Ltd. (Japan)
In September 2017, Mevion Medical Systems announced the submission of 510 (K) premarket notifications to U.S. Food and Drug Administration for its proton therapy system MEVION S250i with pencil beam hyper scan technology.
In October 2014, Hitachi Ltd. And its development partner, Hokkaido University launched a new single room compact 360-degree proton beam therapy system
KEY FEATURES OF THE REPORT:
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. EXECUTIVE SUMMARY
2. GLOBAL PROTON THERAPY MARKET INTRODUCTION
2.1. Global Proton Therapy Market – Taxonomy
2.2. Global Proton Therapy Market –Definitions
2.2.1. System Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL PROTON THERAPY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Proton Therapy Market Dynamics – Factors Impact Analysis
3.6. Global Proton Therapy Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Proton Therapy Market – Recent Product Innovations
4. GLOBAL PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PROTON THERAPY MARKET, BY SYSTEM TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Single Room System
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Multi-Room System
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL PROTON THERAPY MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Paediatric Cancer
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Head & Neck Cancer
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Prostate Cancer
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Lung Cancer
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Gastro-Intestinal Cancer
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Brain Cancer
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. GLOBAL PROTON THERAPY MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Radiotherapy Centers
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL PROTON THERAPY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, route of administration, End User and Region, 2017 – 2023
9. NORTH AMERICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Single Room System
9.1.1.2. Multi-Room System
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Pediatric Cancer
9.1.2.2. Head & Neck Cancer
9.1.2.3. Prostate Cancer
9.1.2.4. Lung Cancer
9.1.2.5. Gastro-Intestinal Cancer
9.1.2.6. Brain Cancer
9.1.2.7. Others
9.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Radiotherapy Centers
9.1.3.3. Others
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
9.1.6. North America Proton Therapy Market Dynamics – Trends
10. EUROPE PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Single Room System
10.1.1.2. Multi-Room System
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Pediatric Cancer
10.1.2.2. Head & Neck Cancer
10.1.2.3. Prostate Cancer
10.1.2.4. Lung Cancer
10.1.2.5. Gastro-Intestinal Cancer
10.1.2.6. Brain Cancer
10.1.2.7. Others
10.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Radiotherapy Centers
10.1.3.3. Others
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Proton Therapy Market - By System Type, Application, End User and Country, 2017 – 2023
10.1.6. Europe Proton Therapy Market Dynamics – Trends
11. ASIA-PACIFIC PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Single Room System
11.1.1.2. Multi-Room System
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Pediatric Cancer
11.1.2.2. Head & Neck Cancer
11.1.2.3. Prostate Cancer
11.1.2.4. Lung Cancer
11.1.2.5. Gastro-Intestinal Cancer
11.1.2.6. Brain Cancer
11.1.2.7. Others
11.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Radiotherapy Centers
11.1.3.3. Others
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
11.1.6. Asia-Pacific Proton Therapy Market Dynamics – Trends
12. LATIN AMERICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Single Room System
12.1.1.2. Multi-Room System
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Pediatric Cancer
12.1.2.2. Head & Neck Cancer
12.1.2.3. Prostate Cancer
12.1.2.4. Lung Cancer
12.1.2.5. Gastro-Intestinal Cancer
12.1.2.6. Brain Cancer
12.1.2.7. Others
12.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Radiotherapy Centers
12.1.3.3. Others
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
12.1.6. Latin America Proton Therapy Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Single Room System
13.1.1.2. Multi-Room System
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Pediatric Cancer
13.1.2.2. Head & Neck Cancer
13.1.2.3. Prostate Cancer
13.1.2.4. Lung Cancer
13.1.2.5. Gastro-Intestinal Cancer
13.1.2.6. Brain Cancer
13.1.2.7. Others
13.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Radiotherapy Centers
13.1.3.3. Others
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Proton Therapy Market - Opportunity Analysis Index, Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
13.1.6. MEA Proton Therapy Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. IBA (Ion Beam Applications S.A.) (Belgium)
14.2.2. Hitachi, Ltd. (Japan)
14.2.3. Varian Medical Systems (U.S.)
14.2.4. Mitsubishi Electric Corporation (Japan)
14.2.5. Optivus Proton Therapy, Inc. (U.S.)
14.2.6. Mevion Medical Systems (U.S.)
14.2.7. Advanced Oncotherapy plc (U.K.)
14.2.8. ProTom International Inc, (U.S.)
14.2.9. ProNova Solutions LLC (U.S.)
14.2.10. Sumitomo Heavy Industries, Ltd. (Japan)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL PROTON THERAPY MARKET INTRODUCTION
2.1. Global Proton Therapy Market – Taxonomy
2.2. Global Proton Therapy Market –Definitions
2.2.1. System Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL PROTON THERAPY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Proton Therapy Market Dynamics – Factors Impact Analysis
3.6. Global Proton Therapy Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Proton Therapy Market – Recent Product Innovations
4. GLOBAL PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PROTON THERAPY MARKET, BY SYSTEM TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Single Room System
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Multi-Room System
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL PROTON THERAPY MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Paediatric Cancer
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Head & Neck Cancer
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Prostate Cancer
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Lung Cancer
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Gastro-Intestinal Cancer
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Brain Cancer
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. GLOBAL PROTON THERAPY MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Radiotherapy Centers
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL PROTON THERAPY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, route of administration, End User and Region, 2017 – 2023
9. NORTH AMERICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Single Room System
9.1.1.2. Multi-Room System
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Pediatric Cancer
9.1.2.2. Head & Neck Cancer
9.1.2.3. Prostate Cancer
9.1.2.4. Lung Cancer
9.1.2.5. Gastro-Intestinal Cancer
9.1.2.6. Brain Cancer
9.1.2.7. Others
9.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Radiotherapy Centers
9.1.3.3. Others
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
9.1.6. North America Proton Therapy Market Dynamics – Trends
10. EUROPE PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Single Room System
10.1.1.2. Multi-Room System
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Pediatric Cancer
10.1.2.2. Head & Neck Cancer
10.1.2.3. Prostate Cancer
10.1.2.4. Lung Cancer
10.1.2.5. Gastro-Intestinal Cancer
10.1.2.6. Brain Cancer
10.1.2.7. Others
10.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Radiotherapy Centers
10.1.3.3. Others
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Proton Therapy Market - By System Type, Application, End User and Country, 2017 – 2023
10.1.6. Europe Proton Therapy Market Dynamics – Trends
11. ASIA-PACIFIC PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Single Room System
11.1.1.2. Multi-Room System
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Pediatric Cancer
11.1.2.2. Head & Neck Cancer
11.1.2.3. Prostate Cancer
11.1.2.4. Lung Cancer
11.1.2.5. Gastro-Intestinal Cancer
11.1.2.6. Brain Cancer
11.1.2.7. Others
11.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Radiotherapy Centers
11.1.3.3. Others
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
11.1.6. Asia-Pacific Proton Therapy Market Dynamics – Trends
12. LATIN AMERICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Single Room System
12.1.1.2. Multi-Room System
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Pediatric Cancer
12.1.2.2. Head & Neck Cancer
12.1.2.3. Prostate Cancer
12.1.2.4. Lung Cancer
12.1.2.5. Gastro-Intestinal Cancer
12.1.2.6. Brain Cancer
12.1.2.7. Others
12.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Radiotherapy Centers
12.1.3.3. Others
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Proton Therapy Market - Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
12.1.6. Latin America Proton Therapy Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PROTON THERAPY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. System Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Single Room System
13.1.1.2. Multi-Room System
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Pediatric Cancer
13.1.2.2. Head & Neck Cancer
13.1.2.3. Prostate Cancer
13.1.2.4. Lung Cancer
13.1.2.5. Gastro-Intestinal Cancer
13.1.2.6. Brain Cancer
13.1.2.7. Others
13.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Radiotherapy Centers
13.1.3.3. Others
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Proton Therapy Market - Opportunity Analysis Index, Opportunity Analysis Index, By System Type, Application, End User and Country, 2017 – 2023
13.1.6. MEA Proton Therapy Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. IBA (Ion Beam Applications S.A.) (Belgium)
14.2.2. Hitachi, Ltd. (Japan)
14.2.3. Varian Medical Systems (U.S.)
14.2.4. Mitsubishi Electric Corporation (Japan)
14.2.5. Optivus Proton Therapy, Inc. (U.S.)
14.2.6. Mevion Medical Systems (U.S.)
14.2.7. Advanced Oncotherapy plc (U.K.)
14.2.8. ProTom International Inc, (U.S.)
14.2.9. ProNova Solutions LLC (U.S.)
14.2.10. Sumitomo Heavy Industries, Ltd. (Japan)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
